
Dr Reddy’s prepares for Q4 headwinds in the US market
Pharma major Dr Reddy’s Laboratories is preparing for challenges in the US market which are expected in the fourth quarter of the current fiscal. “One of our key products in the US will face increased competition beginning February 2026 with an …